This is a multicenter, retrospective and prospective observational study. The research will include 300 patients treated with clinical practice oncological treatments (approved by Italian Competent Authority, AIFA) from January 2012 to February 2024.~Patients will follow the prescribed therapeutic indications according to regular clinical practice and data from their medical records will be collected in a study database.~Primary objective of the study is the evaluation of the type, frequency and severity of skin toxicities related to oncological treatment.~Secondary objectives are:~Evaluation of the association between skin toxicities due to oncological treatment and drug activity and effectiveness parameters(ORR, PFS, OS);~Evaluation of the association between clinical-pathological features of primary cancer and skin toxicities of oncological treatment;~Evaluation of the optimal management of skin toxicities related to cancer treatment.
This is a multicenter, retrospective and prospective observational study. The project involves the collection of clinical data of patients treated with oncological therapies, to evaluate skin toxicities related to oncological treatment.